V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019761 | 220019900 | 1.66 | 39.15 | Not known (9) | 2018-01-28 | 2018-06-01 | Clofarabine + Cytarabine | 2 | N | 220033134 | PONATINIB |
| 220019762 | 220014732 | 0 | 84 | Curative (C) | 2016-03-21 | 2016-03-23 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220033151 | ALEMTUZUMAB |
| 220019763 | 220008826 | null | 53.7 | Curative (C) | 2017-11-10 | 2017-11-23 | GEMTUZUMAB OZOGAMICIN | N | N | 220033156 | GEMTUZUMAB OZOGAMICIN |
| 220019764 | 220008831 | null | 88 | Curative (C) | 2014-05-08 | 2014-06-24 | Clofarabine + Cytarabine | null | null | 220033173 | METHOTREXATE |
| 220019765 | 220008836 | 1.75 | 63.1 | Disease modification (D) | 2018-03-14 | 2018-04-04 | CISPLATIN + GEMCITABINE | N | N | 220033223 | FBC |
| 220019767 | 220008838 | null | 74.8 | Curative (C) | 2013-10-27 | 2013-10-29 | Arsenic trioxide + Tretinoin | N | N | 220033231 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019768 | 220019903 | 1.8 | 64 | Palliative (P) | null | 2016-06-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220033238 | CISPLATIN + GEMCITABINE |
| 220019769 | 220008842 | 1.75 | 85.6 | Curative (C) | 2017-05-18 | 2017-05-23 | METHOTREXATE | N | N | 220033249 | METHOTREXATE |
| 220019770 | 220008844 | null | 97.7 | Palliative (P) | 2016-07-14 | 2016-07-15 | GEMTUZUMAB OZOGAMICIN | N | N | 220033250 | OXALIPLATIN + MDG |
| 220019771 | 220008850 | 1.6 | 68 | Curative (C) | 2017-04-02 | 2017-04-09 | Docetaxel | 02 | N | 220033259 | GEMTUZUMAB OZOGAMICIN |
| 220019772 | 220014745 | 1.76 | null | Palliative (P) | 2018-01-13 | 2018-02-23 | Carboplatin + Etoposide iv&po | 02 | null | 220033272 | CARBOPLATIN + ETOPOSIDE |
| 220019773 | 220014746 | 1.8 | null | Curative (C) | 2013-10-03 | 2013-10-04 | Cisplatin+Gemcitabine (gallbladder) | 2 | N | 220033287 | ECX |
| 220019774 | 220008858 | 1.78 | 106 | Palliative (P) | null | 2017-07-05 | Oxaliplatin + Modified de Gramont | 02 | N | 220033294 | IRINOTECAN + MDG |
| 220019775 | 220008866 | 1.83 | null | Curative (C) | null | 2017-02-11 | Oxaliplatin + Modified de Gramont | N | N | 220033348 | OXALIPLATIN + MDG |
| 220019776 | 220008868 | 1.55 | 64 | Curative (C) | 2014-09-09 | 2015-02-12 | UKALL14- Intens/CNS Proph | null | null | 220033375 | OXALIPLATIN + MDG |
| 220019777 | 220008872 | 1.75 | 99.1 | Curative (C) | 2016-01-27 | 2016-02-09 | Irinotecan + Modified De Gramont | N | N | 220033397 | DOCETAXEL |
| 220019778 | 220008874 | 1.75 | 59.3 | Palliative (P) | 2015-09-11 | 2015-10-09 | Oxaliplatin + Modified de Gramont | N | N | 220033438 | OXALIPLATIN + MDG |
| 220019779 | 220008875 | 1.67 | null | Palliative (P) | 2014-12-02 | 2014-12-04 | METHOTREXATE | 2 | N | 220033442 | PONATINIB |
| 220019780 | 220008878 | 1.79 | 92.9 | Curative (C) | 2015-10-11 | 2015-11-20 | Carboplatin + Etoposide iv&po | null | null | 220033445 | CARBOPLATIN + ETOPOSIDE |
| 220019781 | 220008879 | 1.84 | 88.9 | Disease modification (D) | 2016-08-27 | 2017-02-18 | Paclitaxel 7 day | null | null | 220033448 | PACLITAXEL |
| 220019782 | 220008881 | 1.88 | 56.6 | Curative (C) | 2018-07-21 | 2018-07-21 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220033449 | DOCETAXEL |
| 220019783 | 220008885 | 1.74 | 77.8 | Curative (C) | 2018-10-13 | 2018-10-14 | PACLITAXEL | 02 | N | 220033473 | PACLITAXEL |
| 220019784 | 220008887 | 1.72 | 96.5 | Curative (C) | 2018-04-14 | 2018-06-04 | IDARUBICIN | 2 | N | 220033474 | IDARUBICIN |
| 220019785 | 220008890 | 1.72 | 28.3 | Disease modification (D) | 2016-04-04 | 2016-06-24 | IDARUBICIN | 2 | null | 220033475 | IDARUBICIN |
| 220019786 | 220014762 | 1.7 | 70 | Curative (C) | 2017-01-31 | 2017-02-02 | Clofarabine + Cytarabine | N | N | 220033484 | METHOTREXATE |
| 220019787 | 220008898 | 1.58 | 74 | Curative (C) | 2016-05-16 | 2016-05-16 | CARBOPLATIN + ETOPOSIDE | 02 | N | 220033508 | CARBOPLATIN + ETOPOSIDE |
| 220019788 | 220008902 | 1.59 | null | Curative (C) | 2015-11-25 | 2015-12-14 | Mitox + Tretinoin Spanish Course 3 | Y | N | 220033511 | MITOXANTRONE |
| 220019789 | 220008906 | null | 130 | Curative (C) | 2016-11-14 | 2016-12-25 | Mitoxantrone | N | N | 220033515 | MITOXANTRONE |
| 220019790 | 220018073 | 1.54 | 68 | Not known (9) | 2016-11-17 | 2016-11-17 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 220033519 | PACLITAXEL |
| 220019791 | 220021913 | null | 43 | Curative (C) | 2016-05-16 | 2016-05-16 | ECX | N | N | 220033520 | OXALIPLATIN + MDG |
| 220019792 | 220008911 | null | 62.6 | Curative (C) | 2016-05-26 | 2016-05-26 | Cytarabine intrathecal | N | null | 220033551 | CYTARABINE INTRATHECAL |
| 220019793 | 220008913 | null | 91.9 | Curative (C) | 2018-07-17 | 2018-07-17 | CARBOPLATIN + ETOPOSIDE | 02 | N | 220033567 | CARBOPLATIN + ETOPOSIDE |
| 220019794 | 220008916 | 1.68 | 66.8 | Curative (C) | 2015-09-18 | 2015-10-14 | METHOTREXATE | 2 | N | 220033571 | UKALL2014 |
| 220019795 | 220014778 | 1.68 | 60 | Curative (C) | 2017-01-04 | 2017-01-19 | Cytarabine intrathecal | N | null | 220033680 | CYTARABINE INTRATHECAL |
| 220019796 | 220018081 | 1.9 | 98.7 | Palliative (P) | 2017-02-06 | 2017-02-06 | Clofarabine + Cytarabine | null | null | 220033681 | IRINOTECAN + MDG |
| 220019797 | 220014781 | null | 62.3 | Palliative (P) | 2015-11-01 | 2015-12-12 | Arsenic trioxide + Tretinoin | 02 | N | 220033699 | ARSENIC TRIOXIDE + TRETINOIN |
| 220019798 | 220014781 | null | 85 | Curative (C) | 2015-12-22 | 2016-03-05 | FLUOROURACIL + OXALIPLATIN | null | N | 220033699 | UKALL2014 |
| 220019799 | 220014782 | 1.79 | 0 | Palliative (P) | 2016-07-17 | 2019-02-24 | Mitoxantrone | 2 | N | 220033709 | MITOXANTRONE |
| 220019800 | 220014782 | 1.76 | 89 | Curative (C) | 2014-06-18 | 2014-11-04 | Methotrexate + Folinic acid | 2 | N | 220033709 | PONATINIB |
| 220019801 | 220008945 | null | 77.2 | Curative (C) | 2016-03-23 | 2016-09-25 | Paclitaxel 80mg/m2 day 1 8 15 | Y | N | 220033720 | PACLITAXEL |
| 220019802 | 220008949 | null | 53.5 | Disease modification (D) | 2015-12-07 | 2015-12-14 | Cytarabine+Methotrexate Intrathecal | N | Y | 220033737 | BUSULFAN + CYCLOPHOSPHAMIDE |
| 220019803 | 220008958 | null | 9.2 | Adjuvant (A) | 2017-06-21 | 2017-06-21 | Alemtuzumab+Busulfan+CyclophosphMUD | N | null | 220033807 | MYELOMA XI TRIAL |
| 220019804 | 220008967 | 1.79 | 68 | Disease modification (D) | 2017-04-29 | 2018-05-05 | Busulfan + Cyclophos Conditioning | 01 | N | 220033808 | UKALL 2011 |
| 220019805 | 220014796 | 0 | 74.6 | Curative (C) | 2016-04-28 | 2016-08-08 | VIOLA TRIAL | N | N | 220033810 | RAVVA TRIAL |
| 220019806 | 220008972 | 1.41 | null | Palliative (P) | 2013-10-09 | 2013-10-09 | Bortezomib +/- Dexamethasone | null | null | 220033816 | OCTREOTIDE |
| 220019807 | 220019928 | 1.64 | 52.9 | Palliative (P) | null | 2016-03-10 | VINORELBINE | N | N | 220033832 | CLOFARABINE + CYCLO + CYTARABINE + ETOP |
| 220019808 | 220008978 | 0 | 63 | Palliative (P) | 2018-12-30 | 2019-01-13 | IPO | 02 | N | 220033850 | FLUOROURACIL |
| 220019809 | 220008982 | 1.6 | 71.5 | Palliative (P) | 2018-05-17 | 2018-05-18 | FIGARO TRIAL | 2 | null | 220033857 | FIGARO TRIAL |
| 220019810 | 220008994 | 1.8 | 69 | Disease modification (D) | 2015-06-11 | 2015-09-18 | TRASTUZUMAB | N | N | 220033898 | BUSULPHAN + CYCLO |
| 220019812 | 220009001 | 1.65 | 72.8 | Curative (C) | 2013-09-16 | 2013-09-16 | VIOLA TRIAL | N | N | 220033931 | VINORELBINE |